CORI Corium International, Inc.

3.63
+0  (1%)
Previous Close 3.59
Open 3.59
Price To book 0.00
Market Cap 106.08M
Shares 29,224,000
Volume 26,814
Short Ratio 2.23
Av. Daily Volume 151,713

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

CRL issued 2013. Phase 3 top-line data released January 3, 2017 - poor data but partner Agile Therapeutics (AGRX) intends to reflile NDA 1H 2017.
Twirla
Contraceptive patch
Pilot bioequivalence initiated 4Q 2016. Data due May 2017. Pivotal trial to commence later in 2017, with data mid-2018.
Corplex Donepezil
Alzheimer's disease
Phase 2a data released July 2015
MicroCor PTH
Osteoporosis
Additional Phase 3 required following rejection of NDA. Trial is ongoing by partner Agile
AG200-15
Contraceptive

Latest News

  1. Corium to Participate in BioPharma Dealmakers Webcast on New Innovations in Drug Delivery Technology
  2. Corium International, Inc. :CORI-US: Earnings Analysis: Q1, 2017 By the Numbers : March 20, 2017
  3. Corium Reports Positive Progress in Pilot Bioequivalence Study of Once-Weekly Corplex™ Donepezil Patch
  4. CORIUM INTERNATIONAL, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders
  5. CORIUM INTERNATIONAL, INC. Financials
  6. Edited Transcript of CORI earnings conference call or presentation 13-Feb-17 10:00pm GMT
  7. CORIUM INTERNATIONAL, INC. Files SEC form 10-Q, Quarterly Report
  8. Corium reports 1Q loss
  9. Corium reports 1Q loss
  10. CORIUM INTERNATIONAL, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements an
  11. Corium Reports First Quarter Fiscal 2017 Financial Results
  12. Q1 2017 Corium International Inc Earnings Release - After Market Close
  13. Corium to Present at Upcoming Investor Conferences
  14. Corium to Report First Quarter Fiscal Year 2017 Financial Results on Monday, February 13, 2017
  15. CORIUM INTERNATIONAL, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial St
  16. Corium Prices Follow-On Offering of Common Stock
  17. Corium Announces Proposed Public Offering of Common Stock
  18. CORIUM INTERNATIONAL, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and E
  19. CORIUM INTERNATIONAL, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
  20. ETFs with exposure to Corium International, Inc. : January 6, 2017
  21. ETFs with exposure to Corium International, Inc. : December 23, 2016
  22. Corium International, Inc. :CORI-US: Earnings Analysis: 2016 By the Numbers : December 23, 2016
  23. CORIUM INTERNATIONAL, INC. Files SEC form 10-K, Annual Report
  24. Corium Reports Fourth Quarter and Fiscal Year 2016 Financial Results and Recent Corporate Highlights
  25. Corium to Report Fourth Quarter and Year-end Fiscal Year 2016 Financial Results on Monday, November 21, 2016
  26. Corium to Present at Dawson James Securities Growth Stock Conference
  27. Corium Announces Streamlined Bioequivalence Development Path for Transdermal Corplex™ Memantine
  28. Corium Reports Third Quarter Fiscal 2016 Financial Results and Recent Corporate Highlights
  29. Corium to Report Third Quarter Fiscal Year 2016 Financial Results on Thursday, August 4, 2016
  30. Corium Presents Full Clinical Results from Phase 1 Pharmacokinetic Study of Once-weekly Corplex™ Donepezil Transdermal System
  31. Corium to Present at Cantor Fitzgerald's 2nd Annual Healthcare Conference
  32. Corium to Present at the Jefferies 2016 Healthcare Conference
  33. Corium Reports Second Quarter Fiscal 2016 Financial Results and Recent Corporate Highlights
  34. Corium to Report Second Quarter Fiscal Year 2016 Financial Results on Tuesday, May 10, 2016
  35. Corium Announces Streamlined Bioequivalence Development Path for Transdermal Corplex™ Donepezil Following Positive Pre-IND Communication from FDA
  36. Corium to Present at 15th Annual Needham Healthcare Conference
  37. Corium Announces Positive Preclinical Results with Long-acting Potent GLP-1 Analog Delivered in MicroCor® Transdermal Patch